THE BROOKLYN MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
William Barney Solomon
Suny Downstate Medical Center, Brooklyn, Ny 11203
Grant 2U10CA114671-04 from National Cancer Institute
Abstract: The SUNY Downstate M-B CCOP currently provides the administrative infrastructure for the conduct of cancer control, prevention and treatment trials at its two component hospitals University Hospital of Brooklyn and Kings County Hospital Center. Operation of the SUNY Downstate M-B CCOP commenced 10/1/07, since then the M-B CCOP has dramatically strengthened the ability of our component hospitals to conduct NCI-sponsored clinical trials. For the first time we have enrolled medical oncology patients into treatment studies via ECOG. The M-B CCOP has also become a member of the FCRB and MD Anderson cancer control research bases and has successfully accrued patients to smoking cessation and other trials. The M-B CCOP works very closely with SUNY´s School of Public Health and has conducted numerous meetings, surveys, interviews to help ascertain the barriers to enrollment of minority and underserved patient populations to clinical trials. Since its inception the SUNY M-B CCOP has worked assiduously to create a culture of clinical trials at its two component hospitals. The current renewal proposal is aimed at continuing the efforts of the M-B CCOP to bring state-of-the-art clinical trials to Brooklyn. To this end the M-B CCOP will continue its work with its two component hospitals and proposes to extend its administrative infrastructure to two affiliate hospitals Maimonides and Brookdale. RELEVANCE The SUNY Downstate M-B CCOP has direct impact on the lives of minority and underserved patients who have cancer. It brings state-of-the-art cancer control, prevention and cancer treatment trials to Brooklyn. Enrollment of patients into clinical trials is the only scientific method to advance our understanding of what works and what doesn´t work to aide individuals with cancers
Keywords: 21+ years old; Adult; Adult T-Cell Leukemia-Lymphoma Virus I; Arts; Breast; CCOP; Cancer Center; Cancer Control; Cancer Control Research; Cancer Control Science; Cancer Screening for Patients; Cancer Treatment; Cancer of Breast; Cancer of Lung; Cancers; Cessation of smoking; Clinical Trials; Clinical Trials, Unspecified; Communities; Community Clinical Oncology Program; Community Oncology; County Hospitals; Data; ECOG; Eastern Cooperative Oncology Group; Enrollment; Epidemic; Epidermoid Cell Cancer; Funding; Grant; HOSP; HTLV-1; HTLV-I; HTLV1; Head and Neck; Head and neck structure; Hospitals; Human T-Lymphotropic Virus, Type I; Human T-lymphotropic virus 1; Human, Adult; Individual; Infrastructure; Institution; Interview; Leukemia, T-Cell; Life; Lymphocytic Leukemia, T-Cell; Malignant Epidermoid Cell Neoplasm; Malignant Epidermoid Cell Tumor; Malignant Neoplasm Therapy; Malignant Neoplasm Treatment; Malignant Neoplasms; Malignant Squamous Cell Neoplasm; Malignant Squamous Cell Tumor; Malignant Tumor; Malignant Tumor of the Breast; Malignant Tumor of the Lung; Malignant neoplasm of breast; Malignant neoplasm of lung; Medical Oncology; Medical center; Methods; Minority; Minority-Based Community Clinical Oncology Program; Monitoring Clinical Trials; Multiple Myeloma; Myeloma, Plasma-Cell; Nature; Oncology Programs; Operation; Operative Procedures; Operative Surgical Procedures; Patient Participation; Patients; Physicians; Population; Prevention; Principal Investigator; Programs (PT); Programs [Publication Type]; Public Health Schools; Pulmonary Cancer; Pulmonary malignant Neoplasm; Research Infrastructure; Running; Screening for cancer; Squamous Cell Cancers; Staging; Surgical; Surgical Interventions; Surgical Procedure; Survey Instrument; Surveys; T-Cell Leukemia; T-Cell Leukemia Virus I, Human; T-Lymphocytic Leukemia; Time; Underrepresented Minority; University Hospitals; Virus-HTLV-I; Work; adult human (21+); anticancer therapy; base; cancer prevention; cancer therapy; cease smoking; clinical investigation; early cancer detection; enroll; hormone refractory prostate cancer; human T cell lymphoma virus I; human T cell lymphoma virus type I; human T cell lymphotropic virus 1; human T cell lymphotropic virus type 1; human T lymphotropic virus I; human T-cell leukemia virus type 1; leukemia/lymphoma; lung cancer; lymphoma/leukemia; malignancy; malignant breast neoplasm; meetings; member; myeloma; myelomatosis; neoplasm/cancer; patient population; programs; smoking cessation; surgery; treatment program; treatment trial; under-represented minority; underserved minority
Project start date: 2007-09-07
Project end date: 2015-05-31
Budget start date: 3-JUN-2010
Budget end date: 31-MAY-2011
PFA/PA: RFA-CA-09-023
2U10CA114671-04 (2010): $534190
Sponsored Links Excellgen http://Excellgen.com
Grants awarded to William Barney Solomon
THE BROOKLYN MINORITY-BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
William Barney Solomon
Suny Downstate Medical Center, Brooklyn, Ny 11203
Grant 3U10CA114671-04S1 from National Cancer Institute
Abstract: The SUNY Downstate M-B CCOP currently provides the administrative infrastructure for the conduct of cancer control, prevention and treatment trials at its two component hospitals University Hospital of Brooklyn and Kings County Hospital Center. Operation of the SUNY Downstate M-B CCOP commenced 10/1/07, since then the M-B CCOP has dramatically strengthened the ability of our component hospitals to conduct NCI-sponsored clinical trials. For the first time we have enrolled medical oncology patients into treatment studies via ECOG. The M-B CCOP has also become a member of the FCRB and MD Anderson cancer control research bases and has successfully accrued patients to smoking cessation and other trials. The M-B CCOP works very closely with SUNY´s School of Public Health and has conducted numerous meetings, surveys, interviews to help ascertain the barriers to enrollment of minority and underserved patient populations to clinical trials. Since its inception the SUNY M-B CCOP has worked assiduously to create a culture of clinical trials at its two component hospitals. The current renewal proposal is aimed at continuing the efforts of the M-B CCOP to bring state-of-the-art clinical trials to Brooklyn. To this end the M-B CCOP will continue its work with its two component hospitals and proposes to extend its administrative infrastructure to two affiliate hospitals Maimonides and Brookdale. RELEVANCE The SUNY Downstate M-B CCOP has direct impact on the lives of minority and underserved patients who have cancer. It brings state-of-the-art cancer control, prevention and cancer treatment trials to Brooklyn. Enrollment of patients into clinical trials is the only scientific method to advance our understanding of what works and what doesn´t work to aide individuals with cancers
Project start date: 2007-09-07
Project end date: 2015-05-31
Budget start date: 3-JUN-2010
Budget end date: 31-MAY-2011
PFA/PA: RFA-CA-09-023
3U10CA114671-04S1 (2010): $99947
3U10CA114671-04S2 (2010): $147852
5U10CA114671-03 (2009): $523248
SUNY Downstate Medical Center Minority-Based Community Clinical Oncology Program
William Barney Solomon
Suny Downstate Medical Center 450 Clarkson Avenue Brooklyn, Ny 11203
Grant 1U10CA114671-01A1 from National Cancer Institute IRG: ZCA1
Abstract: The proposed SUNY Downstate Medical Center M-B CCOP will unite the cancer prevention and clinical trials programs at two academic/ teaching hospitals, the University Hospital of Brooklyn and Kings County Hospital Center. Project activities will facilitate and dramatically strengthen the ability to conduct NCI-sponsored cancer treatment and prevention programs at these institutions; thus, making such programs readily available to the predominantly minority population of central Brooklyn, NY. The Project will utilize the Eastern Cooperative Oncology Group as its major research base, and involve continuing participation in other groups including Radiation Therapy Oncology Group, Gynecologic Oncology Group, and American College of Surgical Oncologists Group. Establishment of the SUNY Downstate Medical Center M-B CCOP will foster the participation of a predominantly minority population in state-of-the-art cancer treatment and prevention trials hitherto unavailable to this community. Its essential goal is to efficiently and effectively decrease cancer incidence, morbidity, and mortality among minority patients in Brooklyn.
Project start date: 2007-09-07
Project end date: 2010-05-31
1U10CA114671-01A1 (2007): $400000